Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Coronavirus / COVID-19 Pandemic -- Ignore unavailable to you. Want to Upgrade?

To: Triffin who wrote (20467)	2/17/2022 3:04:45 PM
From: Paul Senior	Respond to of 22884

re NVAX. Thanks for this info. I'm a big believer in the superiority of this "old school" protein-based vaccine over the mRNA types. I'm no expert and not very knowledgeable, but I have a full position in the stock, and try to follow the company's progress and news about it.

To: Triffin who wrote (20467)	2/17/2022 6:58:56 PM
From: Savant	3 Recommendations Recommended By Glenn Petersen kidl Triffin Respond to of 22884

T...Hope springs eternal... However, in re: "Since this vaccine is non MRNA it might be the ticket to convince some of the anti-vaxers to finally getting a shot .." Perhaps, some, but antis are antis and with the current state of divisiveness, will likely stay that way...and it's not just anti vaxers, but also anti govt mandaters...Never mind, that there are many, perhaps most, that won't understand, or attempt to understand the difference between the types of vaccines. Adding fuel to the fire, the FDA's stance will just encourage resistance. Sorry to be so negative, but from my vantage point, and view of history....seems to be the case. PS, I've had all 3 shots, will have a fourth, if offered.